Mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase (MGAT3); β1,4-NAcetylglucosaminyltransferase III (GnT-III, GlcNAcT-III)

Handbook of Glycosyltransferases and Related Genes, Second Edition

Volumn 1, Issue , 2014, Pages 209-222

  Ikeda, Yoshitaka ^a   Ihara, Hideyuki ^a   Tsukamoto, Hiroki ^a   Gu, Jianguo ^b   Taniguchi, Naoyuki ^c  

^a SAGA UNIVERSITY   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^c RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012103175     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-4-431-54240-7_58     Document Type: Chapter

References (79)

1. Akama R, Sato Y, Kariya Y, Isaji T, Fukuda T, Lu L, Taniguchi N, Ozawa M, Gu J (2008) N-Acetylglucosaminyltransferase III expression is regulated by cell-cell adhesion via the E-cadherin-catenin-actin complex. Proteomics 8: 3221-3228
2. Akasaka-Manya K, Manya H, Sakurai Y, Wojczyk BS, Kozutsumi Y, Saito Y, Taniguchi N, Murayama S, Spitalnik SL, Endo T (2010) Protective effect of N-glycan bisecting GlcNAc residues on beta-amyloid production in Alzheimer’s disease. Glycobiology 20: 99-106. doi: 10.1093/glycob/cwp152
3. Allen SD, Tsai D, Schachter H (1984) Control of glycoprotein synthesis. The in vitro synthesis by hen oviduct membrane preparations of hybrid asparagine-linked oligosaccharides containing 5 mannose residues. J Biol Chem 259: 6984-6990
4. Bendiak B, Schachter H (1987) Control of glycoprotein synthesi. Kinetic mechanism, substrate specificity, and inhibition characteristics of UDP-N-acetylglucosamine: alpha-d-mannoside beta 1-2 N-acetylglucosaminyltransferase II from rat liver. J Biol Chem 262: 5784-5790
5. Bhattacharyya R, Bhaumik M, Raju TS, Stanley P (2002) Truncated, inactive N-acetylglucosaminyltransferase III (GlcNAc-TIII) induces neurological and other traits absent in mice that lack GlcNAc-TIII. J Biol Chem 277: 26300-26309. doi: 10.1074/jbc.M202276200
6. Bhaumik M, Seldin MF, Stanley P (1995) Cloning and chromosomal mapping of the mouse Mgat3 gene encoding N-acetylglucosaminyltransferase III. Gene 164: 295-300
7. Bhaumik M, Harris T, Sundaram S, Johnson L, Guttenplan J, Rogler C, Stanley P (1998) Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression. Cancer Res 58: 2881-2887
8. Brockhausen I, Carver JP, Schachter H (1988) Control of glycoprotein synthesis. The use of oligosaccharide substrates and HPLC to study the sequential pathway for N-acetylglucosaminyltransferases I, II, III, IV, V, and VI in the biosynthesis of highly branched N-glycans by hen oviduct membranes. Biochem Cell Biol 66: 1134-1151
9. Fiala M, Liu PT, Espinosa-Jeffrey A, Rosenthal MJ, Bernard G, Ringman JM, Sayre J, Zhang L, Zaghi J, Dejbakhsh S, Chiang B, Hui J, Mahanian M, Baghaee A, Hong P, Cashman J (2007) Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer’s disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci USA 104: 12849-12854. doi: 10.1073/pnas.0701267104
10. Fiala M, Mahanian M, Rosenthal M, Mizwicki MT, Tse E, Cho T, Sayre J, Weitzman R, Porter V (2011) MGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimer’s disease by vitamin D and curcuminoids. J Alzheimers Dis 25: 135-144. doi: 10.3233/JAD-2011-101950
11. Fujimura T, Kurome M, Murakami H, Takahagi Y, Matsunami K, Shimanuki S, Suzuki K, Miyagawa S, Shirakura R, Shigehisa T, Nagashima H (2004) Cloning of the transgenic pigs expressing human decay accelerating factor and N-acetylglucosaminyltransferase III. Cloning Stem Cells 6: 294-301. doi: 10.1089/clo.2004.6.294
12. Fujita T, Machida K, Matsumoto Y, Saito T, Sato N, Takahagi Y, Murakami H, Miyagawa S, Shirakura R, Taniguchi N (2003) Cynomolgus monkey did not hyperacutely reject skin xenograft of N-acetylglucosaminyltransferase III gene transgenic pig. Transplant Proc 35: 518
13. Fujita T, Miyagawa S, Ezoe K, Saito T, Sato N, Takahagi Y, Murakami H, Matsunami K, Shirakura R, Taniguchi N (2004) Skin graft of double transgenic pigs of N-acetylglucosaminyltransferase III (GnT-III) and DAF (CD55) genes survived in cynomolgus monkey for 31 days. Transpl Immunol 13: 259-264. doi: 10.1016/j.trim.2004.08.001
14. Fukuta K, Abe R, Yokomatsu T, Omae F, Asanagi M, Makino T (2000) Control of bisecting GlcNAc addition to N-linked sugar chains. J Biol Chem 275: 23456-23461. doi: 10.1074/jbc.M002693200
15. Galili U (2001) The alpha-Gal epitope (Galalpha1-3Galbeta1-4GlcNAc-R) in xenotransplantation. Biochimie 83: 557-563
16. Garner OB, Baum LG (2008) Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling. Biochem Soc Trans 36: 1472-1477. doi: 10.1042/BST0361472
17. Gleeson PA, Schachter H (1983) Control of glycoprotein synthesis. J Biol Chem 258: 6162-6173
18. Gu J, Taniguchi N (2008) Potential of N-glycan in cell adhesion and migration as either a positive or negative regulator. Cell Adh Migr 2: 243-245
19. Gu J, Sato Y, Kariya Y, Isaji T, Taniguchi N, Fukuda T (2009) A mutual regulation between cell-cell adhesion and N-glycosylation: implication of the bisecting GlcNAc for biological functions. J Proteome Res 8: 431-435
20. Gu J, Isaji T, Xu Q, Kariya Y, Gu W, Fukuda T, Du Y (2012) Potential roles of N-glycosylation in cell adhesion. Glycoconj J 29: 599-607
21. Ihara Y, Nishikawa A, Tohma T, Soejima H, Niikawa N, Taniguchi N (1993) cDNA cloning, expression, and chromosomal localization of human N-acetylglucosaminyltransferase III (GnT-III). J Biochem 113: 692-698
22. Ihara Y, Sakamoto Y, Mihara M, Shimizu K, Taniguchi N (1997) Overexpression of N-acetylglucosaminyltransferase III disrupts the tyrosine phosphorylation of Trk with resultant signaling dysfunction in PC12 cells treated with nerve growth factor. J Biol Chem 272: 9629-9634
23. Ihara Y, Yoshimura M, Miyoshi E, Nishikawa A, Sultan AS, Toyosawa S, Ohnishi A, Suzuki M, Yamamura K, Ijuhin N, Taniguchi N (1998) Ectopic expression of N-acetylglucosaminyltransferase III in transgenic hepatocytes disrupts apolipoprotein B secretion and induces aberrant cellular morphology with lipid storage. Proc Natl Acad Sci USA 95: 2526-2530
24. Ihara H, Ikeda Y, Koyota S, Endo T, Honke K, Taniguchi N (2002) A catalytically inactive beta 1,4-N-acetylglucosaminyltransferase III (GnT-III) behaves as a dominant negative GnT-III inhibitor. Eur J Biochem 269: 193-201
25. Iijima J, Zhao Y, Isaji T, Kameyama A, Nakaya S, Wang X, Ihara H, Cheng X, Nakagawa T, Miyoshi E, Kondo A, Narimatsu H, Taniguchi N, Gu J (2006) Cell-cell interaction-dependent regulation of N-acetylglucosaminyltransferase III and the bisected N-glycans in GE11 epithelial cells: involvement of E-cadherin-mediated cell adhesion. J Biol Chem 281: 13038-13046
26. Ikeda Y, Koyota S, Ihara H, Yamaguchi Y, Korekane H, Tsuda T, Sasai K, Taniguchi N (2000) Kinetic basis for the donor nucleotide-sugar specificity of beta1, 4-N-acetylglucosaminyltransferase III. J Biochem 128: 609-619
27. Isaji T, Gu J, Nishiuchi R, Zhao Y, Takahashi M, Miyoshi E, Honke K, Sekiguchi K, Taniguchi N (2004) Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration. J Biol Chem 279: 19747-19754. doi: 10.1074/jbc.M311627200
28. Kariya Y, Kato R, Itoh S, Fukuda T, Shibukawa Y, Sanzen N, Sekiguchi K, Wada Y, Kawasaki N, Gu J (2008) N-Glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc. J Biol Chem 283: 33036-33045. doi: 10.1074/jbc.M804526200
29. Kariya Y, Kawamura C, Tabei T, Gu J (2010) Bisecting GlcNAc residues on laminin-332 down-regulate galectin-3-dependent keratinocyte motility. J Biol Chem 285: 3330-3340. doi: 10.1074/jbc.M109.038836
30. Kitada T, Miyoshi E, Noda K, Higashiyama S, Ihara H, Matsuura N, Hayashi N, Kawata S, Matsuzawa Y, Taniguchi N (2001) The addition of bisecting N-acetylglucosamine residues to E-cadherin down-regulates the tyrosine phosphorylation of beta-catenin. J Biol Chem 276: 475-480. doi: 10.1074/jbc.M006689200
31. Kobata A, Amano J (2005) Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours. Immunol Cell Biol 83: 429-439. doi: 10.1111/j.1440-1711.2005.01351.x
32. Komoda H, Miyagawa S, Omori T, Takahagi Y, Murakami H, Shigehisa T, Ito T, Matsuda H, Shirakura R (2005) Survival of adult islet grafts from transgenic pigs with N-acetylglucosaminyltransferase-III (GnT-III) in cynomolgus monkeys. Xenotransplantation 12: 209-216. doi: 10.1111/j.1399-3089.2005.00206.x
33. Koyota S, Ikeda Y, Miyagawa S, Ihara H, Koma M, Honke K, Shirakura R, Taniguchi N (2001) Down-regulation of the alpha-Gal epitope expression in N-glycans of swine endothelial cells by transfection with the N-acetylglucosaminyltransferase III gene. Modulation of the biosynthesis of terminal structures by a bisecting GlcNAc. J Biol Chem 276: 32867-32874. doi: 10.1074/jbc.M102371200
34. Li W, Takahashi M, Shibukawa Y, Yokoe S, Gu J, Miyoshi E, Honke K, Ikeda Y, Taniguchi N (2007) Introduction of bisecting GlcNAc in N-glycans of adenylyl cyclase III enhances its activity. Glycobiology 17: 655-662. doi: 10.1093/glycob/cwm022
35. Miwa HE, Song Y, Alvarez R, Cummings RD, Stanley P (2012) The bisecting GlcNAc in cell growth control and tumor progression. Glycoconj J 29: 609-618. doi: 10.1007/s10719-012-9373-6
36. Miyagawa S, Nakai R, Yamada M, Tanemura M, Ikeda Y, Taniguchi N, Shirakura R (1999a) Regulation of natural killer cell-mediated swine endothelial cell lysis through genetic remodeling of a glycoantigen. J Biochem 126: 1067-1073
37. Miyagawa S, Tanemura M, Koyota S, Koma M, Ikeda Y, Shirakura R, Taniguchi N (1999b) Masking and reduction of the Galactose-alpha1,3-Galactose (alpha-Gal) epitope, the major xenoantigen in swine, by the glycosyltransferase gene transfection. Biochem Biophys Res Commun 264: 611-614. doi: 10.1006/bbrc.1999.1327
38. Miyagawa S, Murakami H, Takahagi Y, Nakai R, Yamada M, Murase A, Koyota S, Koma M, Matsunami K, Fukuta D, Fujimura T, Shigehisa T, Okabe M, Nagashima H, Shirakura R, Taniguchi N (2001) Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig. J Biol Chem 276: 39310-39319. doi: 10.1074/jbc.M104359200
39. Miyagawa S, Ueno T, Nagashima H, Takama Y, Fukuzawa M (2012) Carbohydrate antigens. Curr Opin Organ Transplant 17: 174-179. doi: 10.1097/MOT.0b013e3283508189
40. Miyoshi E, Nishikawa A, Ihara Y, Gu J, Sugiyama T, Hayashi N, Fusamoto H, Kamada T, Taniguchi N (1993) N-acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis. Cancer Res 53: 3899-3902
41. Miyoshi E, Ihara Y, Hayashi N, Fusamoto H, Kamada T, Taniguchi N (1995) Transfection of N-acetylglucosaminyltransferase III gene suppresses expression of hepatitis B virus in a human hepatoma cell line, HB611. J Biol Chem 270: 28311-28315
42. Nagai K, Ihara Y, Wada Y, Taniguchi N (1997) N-glycosylation is requisite for the enzyme activity and Golgi retention of N-acetylglucosaminyltransferase III. Glycobiology 7: 769-776
43. Nakakita S, Natsuka S, Ikenaka K, Hase S (1998) Development-dependent expression of complex-type sugar chains specific to mouse brain. J Biochem 123: 1164-1168
44. Narasimhan S (1982) Control of glycoprotein synthes. UDP-GlcNAc: glycopeptide beta 4-N-acetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in beta 1-4 linkage to the beta-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides. J Biol Chem 257: 10235-10242
45. Narasimhan S, Schachter H, Rajalakshmi S (1988) Expression of N-acetylglucosaminyltransferase III in hepatic nodules during rat liver carcinogenesis promoted by orotic acid. J Biol Chem 263: 1273-1281
46. Nishikawa A, Fujii S, Sugiyama T, Hayashi N, Taniguchi N (1988a) High expression of an N-acetylglucosaminyltransferase III in 3′-methyl DAB-induced hepatoma and ascites hepatoma. Biochem Biophys Res Commun 152: 107-112
47. Nishikawa A, Fujii S, Sugiyama T, Taniguchi N (1988b) A method for the determination of N-acetylglucosaminyltransferase III activity in rat tissues involving HPLC. Anal Biochem 170: 349-354
48. Nishikawa A, Ihara Y, Hatakeyama M, Kangawa K, Taniguchi N (1992) Purification, cDNA cloning, and expression of UDP-N-acetylglucosamine: beta-d-mannoside beta-1,4N-acetylglucosaminyltransferase III from rat kidney. J Biol Chem 267: 18199-18204
49. Okada T, Ihara H, Ito R, Taniguchi N, Ikeda Y (2009) Bidirectional N-acetylglucosamine transfer mediated by beta-1,4-N-acetylglucosaminyltransferase III. Glycobiology 19: 368-374. doi: 10.1093/glycob/cwn145
50. Okada T, Ihara H, Ito R, Nakano M, Matsumoto K, Yamaguchi Y, Taniguchi N, Ikeda Y (2010) N-Glycosylation engineering of lepidopteran insect cells by the introduction of the beta1,4-N-acetylglucosaminyltransferase III gene. Glycobiology 20: 1147-1159. doi: 10.1093/glycob/cwq080
51. Pinho SS, Seruca R, Gartner F, Yamaguchi Y, Gu J, Taniguchi N, Reis CA (2011) Modulation of E-cadherin function and dysfunction by N-glycosylation. Cell Mol Life Sci 68: 1011-1020. doi: 10.1007/s00018-010-0595-0
52. Pinho SS, Oliveira P, Cabral J, Carvalho S, Huntsman D, Gartner F, Seruca R, Reis CA, Oliveira C (2012) Loss and recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal-epithelial transitions. PLoS One 7: e33191. doi: 10.1371/journal.pone.0033191
53. Priatel JJ, Sarkar M, Schachter H, Marth JD (1997) Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction. Glycobiology 7: 45-56
54. Rebbaa A, Yamamoto H, Saito T, Meuillet E, Kim P, Kersey DS, Bremer EG, Taniguchi N, Moskal JR (1997) Gene transfection-mediated overexpression of beta1,4-N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function. J Biol Chem 272: 9275-9279
55. Sasai K, Ikeda Y, Ihara H, Honke K, Taniguchi N (2003) Caveolin-1 regulates the functional localization of N-acetylglucosaminyltransferase III within the Golgi apparatus. J Biol Chem 278: 25295-25301. doi: 10.1074/jbc.M301913200
56. Sato Y, Takahashi M, Shibukawa Y, Jain SK, Hamaoka R, Miyagawa J, Yaginuma Y, Honke K, Ishikawa M, Taniguchi N (2001) Overexpression of N-acetylglucosaminyltransferase III enhances the epidermal growth factor-induced phosphorylation of ERK in HeLaS3 cells by up-regulation of the internalization rate of the receptors. J Biol Chem 276: 11956-11962. doi: 10.1074/jbc.M008551200
57. Sato Y, Isaji T, Tajiri M, Yoshida-Yamamoto S, Yoshinaka T, Somehara T, Fukuda T, Wada Y, Gu J (2009) An N-glycosylation site on the beta-propeller domain of the integrin alpha5 subunit plays key roles in both its function and site-specific modification by beta1,4-N-acetylglucosaminyltransferase III. J Biol Chem 284: 11873-11881. doi: 10.1074/jbc.M807660200
58. Schachter H (1986) Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Biochem Cell Biol 64: 163-181
59. Schachter H, Narasimhan S, Gleeson P, Vella G (1983) Control of branching during the biosynthesis of asparagine-linked oligosaccharides. Can J Biochem Cell Biol 61: 1049-1066
60. Shimizu H, Ochiai K, Ikenaka K, Mikoshiba K, Hase S (1993) Structures of N-linked sugar chains expressed mainly in mouse brain. J Biochem 114: 334-338
61. Stanley P (2002) Biological consequences of overexpressing or eliminating N-acetylglucosaminyltransferase-TIII in the mouse. Biochim Biophys Acta 1573: 363-368
62. Sultan AS, Miyoshi E, Ihara Y, Nishikawa A, Tsukada Y, Taniguchi N (1997) Bisecting GlcNAc structures act as negative sorting signals for cell surface glycoproteins in for skolin-treated rat hepatoma cells. J Biol Chem 272: 2866-2872
63. Takahagi Y, Fujimura T, Miyagawa S, Nagashima H, Shigehisa T, Shirakura R, Murakami H (2005) Production of alpha 1,3-galactosyltransferase gene knockout pigs expressing both human decay-accelerating factor and N-acetylglucosaminyltransferase III. Mol Reprod Dev 71: 331-338. doi: 10.1002/mrd.20305
64. Takahashi M, Kuroki Y, Ohtsubo K, Taniguchi N (2009) Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins. Carbohydr Res 344: 1387-1390. doi: 10.1016/j.carres.2009.04.031
65. Tanemura M, Miyagawa S, Ihara Y, Matsuda H, Shirakura R, Taniguchi N (1997) Significant downregulation of the major swine xenoantigen by N-acetylglucosaminyltransferase III gene transfection. Biochem Biophys Res Commun 235: 359-364. doi: 10.1006/bbrc.1997.6784
66. Taniguchi N, Korekane H (2011) Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics. BMB Rep 44: 772-781
67. Taniguchi N, Nishikawa A, Fujii S, Gu JG (1989) Glycosyltransferase assays using pyridylaminated acceptors: N-acetylglucosaminyltransferase III, IV, and V. Methods Enzymol 179: 397-408
68. Taniguchi N, Miyoshi E, Ko JH, Ikeda Y, Ihara Y (1999) Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism. Biochim Biophys Acta 1455: 287-300
69. Xu Q, Akama R, Isaji T, Lu Y, Hashimoto H, Kariya Y, Fukuda T, Du Y, Gu J (2011) Wnt/β-catenin signaling down-regulates N-Acetylglucosaminyltransferase III expression: the implication of two mutually exclusive pathways for regulation. J Biol Chem 286: 4310-4318
70. Xu Q, Isaji T, Lu Y, Gu W, Kondo M, Fukuda T, Du Y, Gu J (2012) Roles of N-acetylglucosaminyltransferase III in epithelial-to-mesenchymal transition induced by TGF-β 1 in epithelial cell lines. J Biol Chem 287: 16563-16574
71. Yamashita K, Hitoi A, Tateishi N, Higashi T, Sakamoto Y, Kobata A (1983) Organ-specific difference in the sugar chains of gamma-glutamyltranspeptidase. Arch Biochem Biophys 225: 993-996
72. Yamashita K, Hitoi A, Matsuda Y, Miura T, Katunuma N, Kobata A (1986) Structures of sugar chains of human kidney gamma-glutamyltranspeptidase. J Biochem 99: 55-62
73. Yang X, Bhaumik M, Bhattacharyya R, Gong S, Rogler CE, Stanley P (2000) New evidence for an extra-hepatic role of N-acetylglucosaminyltransferase III in the progression of diethylnitrosamine-induced liver tumors in mice. Cancer Res 60: 3313-3319
74. Yang X, Tang J, Rogler CE, Stanley P (2003) Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III. Cancer Res 63: 7753-7759
75. Yoshimura M, Nishikawa A, Ihara Y, Taniguchi S, Taniguchi N (1995) Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci USA 92: 8754-8758
76. Yoshimura M, Ihara Y, Ohnishi A, Ijuhin N, Nishiura T, Kanakura Y, Matsuzawa Y, Taniguchi N (1996a) Bisecting N-acetylglucosamine on K562 cells suppresses natural killer cytotoxicity and promotes spleen colonization. Cancer Res 56: 412-418
77. Yoshimura M, Ihara Y, Matsuzawa Y, Taniguchi N (1996b) Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J Biol Chem 271: 13811-13815
78. Yoshimura M, Ihara Y, Nishiura T, Okajima Y, Ogawa M, Yoshida H, Suzuki M, Yamamura K, Kanakura Y, Matsuzawa Y, Taniguchi N (1998) Bisecting GlcNAc structure is implicated in suppression of stroma-dependent haemopoiesis in transgenic mice expressing N-acetylglucosaminyltransferase III. Biochem J 331(Pt 3): 733-742
79. Zhao Y, Nakagawa T, Itoh S, Inamori K, Isaji T, Kariya Y, Kondo A, Miyoshi E, Miyazaki K, Kawasaki N, Taniguchi N, Gu J (2006) N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration. J Biol Chem 281: 32122-32130. doi: 10.1074/jbc.M607274200